154
Views
0
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 31-34 | Received 06 Jun 2023, Accepted 08 Aug 2023, Published online: 21 Aug 2023

References

  • Monticelli J, Di Bella S, Giacobbe DR, et al. Trends in the incidence and antibiotic resistance of enterococcal bloodstream isolates: a 7-year retrospective multicenter epidemiological study in Italy. Microb Drug Resist. 2021;27(4):529–535. doi: 10.1089/mdr.2020.0147.
  • Mercuro NJ, Davis SL, Zervos MJ, et al. Combatting resistant enterococcal infections: a pharmacotherapy review. Expert Opin Pharmacother. 2018;19(9):979–992. doi: 10.1080/14656566.2018.1479397.
  • Lagatolla C, Mehat JW, La Ragione RM, et al. In vitro and in vivo studies of oritavancin and fosfomycin synergism against vancomycin-resistant. Antibiotics. 2022;11(10):1334. doi: 10.3390/antibiotics11101334.
  • Yahav D, Franceschini E, Koppel F, et al. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis. 2019;69(7):1091–1098. doi: 10.1093/cid/ciy1054.
  • Bahrs C, Rieg S, Hennigs A, et al. Short-course versus long-course antibiotic treatment for uncomplicated vancomycin-resistant enterococcal bacteraemia: a retrospective multicentre cohort study. Clin Microbiol Infect. 2023;29(2):200–207. doi: 10.1016/j.cmi.2022.08.023.
  • Lee EY, Caffrey AR. Thrombocytopenia with tedizolid and linezolid. Antimicrob Agents Chemother. 2018;62(1):e01453-17. doi: 10.1128/AAC.01453-17.
  • Britt NS, Potter EM, Patel N, et al. Comparative effectiveness and safety of standard-, medium-, and high-dose daptomycin strategies for the treatment of vancomycin-resistant enterococcal bacteremia among veterans affairs patients. Clin Infect Dis. 2017;64(5):605–613.
  • Johnson JA, Feeney ER, Kubiak DW, et al. Prolonged use of oritavancin for vancomycin-resistant Enterococcus faecium prosthetic valve endocarditis. Open Forum Infect Dis. 2015;2(4):ofv156.
  • Carvalhaes CG, Sader HS, Streit JM, et al. Activity of oritavancin against gram-positive pathogens causing bloodstream infections in the United States over 10 years: focus on drug-resistant enterococcal subsets (2010-2019). Antimicrob Agents Chemother. 2022;66(2):e0166721. doi: 10.1128/AAC.01667-21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.